Related references
Note: Only part of the references are listed.Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings
E. Jonasch et al.
BRITISH JOURNAL OF CANCER (2008)
Just enough palliation: Radiation dose and outcome in patients with non-small-cell lung cancer
Henry Wagner
JOURNAL OF CLINICAL ONCOLOGY (2008)
BIIB021, an oral, synthetic non-ansamycin Hsp90 inhibitor: Phase I experience
A. Elfiky et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A Phase 1 dose-escalation study of the safety and pharmacokinetics (PK) of the oral Hsp90 inhibitor SNX-5422
J. C. Bryson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100-21 study group
Alessandro Testori et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
An adjuvant autologous therapeutic vaccine (HSPPC-96 vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentrel, open-label, randomised phase III trial
Christopher Wood et al.
LANCET (2008)
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I Dose-Escalation study
Shanu Modi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy
E. Schmitt et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients
L Pilla et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma
WG Richards et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase I pharmacokinetic and pharmacodynarnic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
U Banerji et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells
R Gastpar et al.
CANCER RESEARCH (2005)
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line
JT Price et al.
CANCER RESEARCH (2005)
Heat shock proteins as molecular chaperones
AP Arrigo
M S-MEDECINE SCIENCES (2005)
Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors
JL Grem et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo
D Tang et al.
CELL STRESS & CHAPERONES (2005)
Hsp70 chaperones: Cellular functions and molecular mechanism
MP Mayer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
MP Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia
A Pfosser et al.
CARDIOVASCULAR RESEARCH (2005)
The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response
ND Trinklein et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Altered states: selectively drugging the Hsp90 cancer chaperone
P Workman
TRENDS IN MOLECULAR MEDICINE (2004)
Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement
WB Pratt et al.
CELLULAR SIGNALLING (2004)
Functional domains of HSP70 stimulate generation of cytokines and chemokines, maturation of dendritic cells and adjuvanticity
T Lehner et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Induction of angiogenesis by heat shock protein 90 mediated by protein kinase akt and endothelial nitric oxide synthase
JX Sun et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets
C Spiess et al.
TRENDS IN CELL BIOLOGY (2004)
Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability
N Arispe et al.
FASEB JOURNAL (2004)
Pathways of chaperone-mediated protein folding in the cytosol
JC Young et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B
C Gross et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice
MH Manjili et al.
JOURNAL OF IMMUNOLOGY (2003)
GRP94 (94 kDa glucose-regulated protein) suppresses ischemic neuronal cell death against ischemia/reperfusion injury
Y Bando et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Clinical significance of heat shock protein-70 expression in bladder cancer
KN Syrigos et al.
UROLOGY (2003)
Perforin is required for innate and adaptive immunity induced by heat shock protein Gp96
N Strbo et al.
IMMUNITY (2003)
Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity
XH Chen et al.
IMMUNOLOGY LETTERS (2002)
Stimulation of Th1-polarizing maturation of dendritic cells, cytokines, C-C chemokines, and adjuvant function by the peptide binding fragment of heat shock protein 70
YF Wang et al.
JOURNAL OF IMMUNOLOGY (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90
GQ Chen et al.
MOLECULAR CELL (2002)
Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90
P Pandey et al.
EMBO JOURNAL (2000)
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis
H Singh-Jasuja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation
J Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
A Asea et al.
NATURE MEDICINE (2000)
A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma
AT Hoang et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
